This is the authors' abstract. We don't add key points for this paper.
Combating the threat of multidrug resistance bacteria requires many different approaches. Using structural motifs and sequences from existing antibacterial compounds affords a fresh attack against such bacteria, while circumventing inherited resistance against the existing compound. Gramicidin is a 16 amino acid peptide with an alternating l - and d -motif with highly bacteriocidal effects in gram-positive membranes. In the membrane it assumes a β -helix form with two peptides aligned by their N-terminal interactions, and only conducts in such a form. Using gramicidin as a basis, this study employs molecular dynamics simulations as an initial design step and evaluates gramicidin-derived candidates based on their backbone hydrogen-bond interactions, capacity for conductance, profile of their RMSD over the course of the simulation, and how the peptide interacts with the phospholipid headgroups. There are twelve candidate systems with results comparable to gramicidin and the factors at play in their efficacy are examined.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lambden et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: